Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged Tempest Therapeutics Inc TPST Q1 2026 Earnings Significant EPS Miss with No Revenue Stock Edges Up Limoneira Co LMNR Q1 2026 Earnings EPS Misses Estimates by Over 42 Amid Challenging Winter Season FCRX Q1 2026 Earnings Slight EPS Miss Reflects Steady Performance Amid Stable Market Conditions PRH Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty FNB Q1 2026 Earnings EPS Misses Estimates Slightly Stock Edges Higher